Uncategorized
Biotechnology

Greenphire: King of Prussia clinical payment tech startup to open office in England

Greenphire, a King of Prussia-based clinical trial payment technology company, is setting its sights on Europe. It’s opening an office in England this year in order to focus on the European market. Founded in 2007, Greenphire provides technology that automates payments for companies that run clinical trials, from smaller trials to global-scale ones. It raised […]

Scrum

Inside Greenphire’s office. Photo courtesy of Greenphire.

Greenphire, a King of Prussia-based clinical trial payment technology company, is setting its sights on Europe. It’s opening an office in England this year in order to focus on the European market.

Founded in 2007, Greenphire provides technology that automates payments for companies that run clinical trials, from smaller trials to global-scale ones. It raised $4.3 million this fall, as we reported, following a $1.5 million series A round in fall 2011 led by New York City-based First Mark Capital.

Check out Greenphire here.

Cofounders John “JP” Samar (left) and Samuel Whitaker. Photo courtesy of Greenphire.

The company’s been growing, too: it more than doubled its staff last year, from 17 to more than 40 staffers.

Greenphire was founded by John “JP” Samar and husband-and-wife pair Samuel Whitaker and Jennifer Peters. Peters and Whitaker, a Penn grad, live in Phoenixville, while Samar, a Lehigh University grad, lives in King of Prussia. They are all in their thirties, according to a spokeswoman.

Companies: First Mark Capital / Greenphire
Engagement

Join the conversation!

Find news, events, jobs and people who share your interests on Technical.ly's open community Slack

Trending

Philly daily roundup: Jason Bannon leaves Ben Franklin; $26M for narcolepsy treatment; Philly Tech Calendar turns one

Philly daily roundup: Closed hospital into tech hub; Pew State of the City; PHL Open for Business

A biotech hub is rising at Philadelphia’s shuttered Hahnemann Hospital campus

Will the life sciences dethrone software as the king of technology?

Technically Media